This is a medication used to treat HIV. It works by stopping the virus from copying itself into your body. It's often taken with other medicines as part of an HIV treatment plan.
Every report comes from a Lived member, sent anonymously.
Have you tried Atripla (Efavirenz/Emtricitabine/Tenofovir) for HIV Infection?
Efavirenz, emtricitabine and tenofovir disoproxil fumarate is a single tablet that combines three medicines for HIV (human immunodeficiency virus) into a complete once-a-day treatment for HIV-1, the most common type. It was sold for years under the brand name Atripla. The Atripla brand is now discontinued in the US, but generic tablets with the same three ingredients and strengths are still available. It is approved for adults and for children who weigh at least 40 kilograms (about 88 pounds), on its own or together with other HIV medicines. HIV treatment has changed since this combination was introduced. Current expert recommendations from the International Antiviral Society-USA favor regimens built around an integrase inhibitor, such as bictegravir or dolutegravir, for most people starting treatment. This tablet remains an approved option, and whether to start it, stay on it or switch is a decision to make with an HIV clinician. It is not a treatment for hepatitis B, and it is a different product from Symfi, a similar tablet that contains lamivudine in place of emtricitabine.
HIV infects CD4 cells, white blood cells that help the body fight infection, and over time it destroys them. To make copies of itself, the virus relies on an enzyme called reverse transcriptase. All three medicines in this tablet target that enzyme, from two different directions. Emtricitabine and tenofovir are nucleoside reverse transcriptase inhibitors (NRTIs), which block the enzyme. Efavirenz is a non-nucleoside reverse transcriptase inhibitor (NNRTI), which attaches to the enzyme and changes it so it no longer works properly. With less new virus being made, the amount of HIV in the blood, called the viral load, falls, and the immune system gets a chance to recover. The medicine does not cure HIV. Some virus remains in the body, which is why treatment continues long term.
Each tablet contains 600 mg of efavirenz, 200 mg of emtricitabine and 300 mg of tenofovir disoproxil fumarate, and the usual dose is one tablet once a day. It is taken on an empty stomach, meaning at least an hour before or two hours after a meal, and preferably at bedtime. Bedtime dosing can make efavirenz's early dizziness and sleep effects easier to tolerate. Taking it at about the same time each day helps. Before starting, the care team tests for hepatitis B, checks kidney and liver function, and offers a pregnancy test to anyone who could become pregnant. The tablet is not recommended for people with moderately or severely reduced kidney function or with moderate to severe liver disease. People who also need rifampin, an antibiotic used for tuberculosis, may be prescribed an extra dose of efavirenz alongside the tablet. If a dose is missed, take it as soon as you remember, unless it is nearly time for the next one. Do not take two doses together to make up for it.
Efavirenz commonly affects the nervous system at first. In clinical trials, about half of people taking it noticed effects such as dizziness, trouble sleeping, poor concentration, drowsiness or unusually vivid dreams, compared with about a quarter of people on other regimens. These usually start within a day or two and ease within two to four weeks. If you feel dizzy or drowsy, avoid driving or other hazardous tasks, and keep in mind that alcohol and other drugs that affect the brain can add to these effects. Diarrhea, nausea, tiredness, headache and rash are also common. The rash usually appears in the first two weeks, is mild and often clears without stopping treatment. Less often, efavirenz has been linked to serious psychiatric effects. Severe depression, thoughts of suicide, aggressive behavior, paranoia or other major changes in mood or thinking need medical evaluation right away. People with a history of mental illness should mention it before starting. Contact the care team promptly about a rash with blistering, peeling skin, mouth sores or fever; signs of liver trouble such as yellowing of the skin or eyes, dark urine, pale stools, or ongoing nausea, tiredness and loss of appetite; or new problems with balance, coordination, confusion or memory, which can rarely develop months or even years into treatment.
Do not stop this medicine without talking to the prescriber first. In people who have both HIV and hepatitis B, stopping emtricitabine or tenofovir can set off a severe flare of hepatitis B that may damage the liver. This is why everyone is tested for hepatitis B before starting, and why people with both infections need liver monitoring for several months after stopping, sometimes with a separate hepatitis B medicine. Efavirenz may harm a developing baby if taken in the first trimester of pregnancy, and the label advises avoiding pregnancy during treatment and for 12 weeks after stopping. Efavirenz also lowers the levels of some hormonal contraceptives, including the etonogestrel birth control implant, so a barrier method such as condoms is recommended in addition to hormonal birth control. Anyone who becomes pregnant or is planning a pregnancy should tell the HIV care team promptly rather than stopping the medicine on their own. Tenofovir disoproxil fumarate can affect the kidneys and slightly lower bone density. Kidney blood and urine tests are done before and during treatment, and high doses or regular use of nonsteroidal anti-inflammatory (NSAID) pain relievers such as ibuprofen or naproxen should be avoided. Persistent bone pain or muscle weakness is worth reporting, because it can be a sign of kidney-related bone problems. Efavirenz changes how the liver handles many other drugs, and some drugs lower efavirenz levels enough to let HIV become resistant. It must not be taken with voriconazole, an antifungal medicine, or with elbasvir/grazoprevir, a hepatitis C treatment. Other important examples include the herbal supplement St. John's wort, methadone (whose dose may need to rise to prevent withdrawal), some seizure medicines and several hepatitis C and HIV medicines. Efavirenz can also affect heart rhythm, which matters for people taking other medicines with the same effect, and it calls for caution in people with a history of seizures. Tell the prescriber and pharmacist about every medicine and supplement, and check before starting anything new.
The first few weeks are often the hardest, because efavirenz's dizziness, sleep and dream effects are strongest early and usually settle within a month. After that, regular blood tests show how well treatment is working. The viral load should fall, and the CD4 count, a measure of immune health, can rise as the immune system recovers. In people with advanced HIV, the recovering immune system sometimes reacts to infections that were already present, causing new inflammation soon after starting, so new signs of infection should be reported. Treatment is long term, and taking every dose matters. Missed doses, or stopping even for a short time, can let the virus become resistant to these medicines and harder to treat. Kidney, liver and other lab checks continue throughout. Efavirenz can cause a false-positive result on some urine screening tests for marijuana, so mention it if you are tested; a more specific test can confirm the result. Regimens are sometimes changed because of side effects, convenience, cost or how well the virus is controlled. If problems persist, a switch can be planned with the HIV clinician rather than by stopping on your own.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share your experience taking Atripla (Efavirenz/Emtricitabine/Tenofovir), what you've noticed, or ask the community a question.